American CryoStem Corporation is a clinical-stage biotechnology company and global licensor that specializes in autologous cellular processing and therapies. With their patented CryoStem Platform, they offer a comprehensive cellular therapy solution for treating injuries, disorders, and chronic diseases using adipose tissue fat harvest and cryopreservation. Their mission is to improve clinical outcomes and enhance patient health and quality of life by developing and delivering cutting-edge stem cell therapies.
As pioneers in the fields of Regenerative and Personalized Medicine, American CryoStem Corporation is dedicated to advancing research, development, and application of stem cell technology. They focus on clinical processing, commercial bio-banking, and application development for adipose fat tissue and autologous adipose-derived regenerative cells (ADRCs). With their expertise and commitment to innovation, they aim to harness the regenerative power of the human body's own building blocks to restore the benefits lost with age and replace damaged cells with new disease-free cells.
Generated from the website